InsiderTrades

Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.

Accepted 2022-02-16 00:00:00 ET · period of report 2022-02-14 · accession 0001439222-22-000011 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-02-16 2022-02-14 AGIO Burns James William CLO M - OptEx $0.00 +6,988 11.2K +166% $0
D 2022-02-16 2022-02-14 AGIO Burns James William CLO F - Tax $30.50 -2,155 14.3K -13% -$65.7K
DM 2022-02-16 2022-02-14 AGIO Burns James William CLO M - OptEx $0.00 -6,988 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common stock 2022-02-14 M A 5,250 $0.00 16,439 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
2 Common Common stock 2022-02-14 M A 1,738 $0.00 11,189 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
3 Common Common stock 2022-02-14 F D 2,155 $30.50 14,284 D — —
4 Derivative Restricted stock units 2022-02-14 M D 1,738 $0.00 1,738 D — · — to — 1,738 Common stock (F1) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. (F2) The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.
5 Derivative Restricted stock units 2022-02-14 M D 5,250 $0.00 0 D — · — to — 5,250 Common stock (F1) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. (F3) The restricted stock units were granted on February 14, 2020. The shares underlying the restricted stock units will vest in full on February 14, 2022.